|
Expert: FDA Improvement in Predictability, Review Requests Is Behind Approval Spike
The FDA is realizing industry’s need for predictability and reasonable data requests during the review process, leading to the uptick in drug approvals seen so far this year, an expert says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives